Free Trial

The Environmental Protection Agency wants to bring back the weed killer dicamba

A farmer shows soybean plants damaged by dicamba in Marvell, Ark., July 11, 2017. (AP Photo/Andrew DeMillo, File)

Key Points

  • EPA proposes reapproval of dicamba for genetically engineered soybeans and cotton, reversing two court blocks in 2020 and 2024 and marking its first absence since 2016.
  • Environmental groups vow to challenge the decision in court, warning that the move endangers ecosystem health and reflects political interference in the EPA.
  • The agency asserts that dicamba is crucial for crop protection, claims it poses no human health or environmental risks, and will open the proposal for 30 days of public comment.
  • Research links dicamba exposure to cancers such as liver cancer and leukemia, and its propensity to drift threatens neighboring farms and wild flora and fauna.
  • Five stocks we like better than Rollins.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

The Environmental Protection Agency has proposed allowing the weed killer dicamba for genetically engineered soybeans and cotton, two crops that are grown extensively in the United States.

This week’s recommendation comes after the first Trump administration made the same move, only to have courts block it in 2020 and 2024. This is the first year since 2016 that dicamba has not been allowed to be used on crops, according to Nathan Donley, the environmental health science director at the Center for Biological Diversity, a national conservation nonprofit.

Environmental groups say they will once again go to court to try to block it.

“This is an unfortunate roller coaster ride that the country has been in for about 10 years now, and it’s just incredibly sad to see our Environmental Protection Agency being hijacked by this administration and facilitating decisions that are objectively going to make our environment less healthy," Donley said.

The EPA said via email that it “will ensure that farmers have the tools they need to protect crops and provide a healthy and affordable food supply for our country” and the agency is “confident these products won’t cause issues for human health or the environment.”

The EPA added that the proposal will be open for public comment for 30 days and included a list of proposed guidelines on the use of the three dicamba-containing products in question.

Dicamba is a common weed killer and has been used for over 50 years in the U.S., but it has become more widespread on farms in the past decade, according to data from the EPA and the U.S. Geological Survey.

Researchers have been working to better understand the health risks it might pose to humans. A 2020 study in the International Journal of Epidemiology found that dicamba exposure was linked to some cancers, including liver cancer and a type of leukemia affecting the blood and bone marrow.

Dicamba can also drift far from its intended targets to kill other plants on neighboring farms and in local ecosystems, posing threats to wild flora and fauna, according to the National Wildlife Federation.

An agency can tweak a decision after a court strikes it down, and then dicamba would be approved until a new legal challenge succeeds. Past court rulings on dicamba have taken years, “leaving many farmers with questions and uncertainty in the middle of the growing season,” National Agricultural Law Center staff attorney Brigit Rollins said in a background summary of dicamba legal cases.

___

Follow Melina Walling on X @MelinaWalling and Bluesky @melinawalling.bsky.social.

___

The Associated Press’ climate and environmental coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.

Should You Invest $1,000 in Rollins Right Now?

Before you consider Rollins, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rollins wasn't on the list.

While Rollins currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines